de Montmollin, E., Tandjaoui-Lambiotte, Y., Legrand, M., Lambert, J., Mokart, D., Kouatchet, A., Lemiale, V., Pène, F., Bruneel, F., Vincent, F., Mayaux, J., Chevret, S. and Azoulay, E. (2013) Outcomes in Critically Ill Cancer Patients with Septic Shock of Pulmonary Origin. Shock, 39, 250-254.
https://doi.org/10.1097/SHK.0b013e3182866d32

has been cited by the following article:

• TITLE: Non-Neutropenic Sepsis in Cancer Patients: The Luminal Obstruction Syndrome

  AUTHORS: Tamás Kullmann, Dóra Füzi, Tamás Pintér

  KEYWORDS: Sepsis, Biliary Sepsis, Urosepsis, Bronchogenic Sepsis, Solid Cancer

  JOURNAL NAME: Journal of Cancer Therapy, Vol.10 No.10, September 29, 2019

  ABSTRACT: Background: Neutropenic sepsis is a frequent complication of cytotoxic chemotherapy delivered for cancer patients. Its management is well determined by clinical guidelines. Non-neutropenic sepsis is another potential complication in cancer patients. Its management is less established in the medical literature. Materials and Methods: Three cases are presented to illustrate favourable evolution of non-neutropenic biliary-, uro- and bronchogenic-sepsis in cancer patients with poor prognosis. Results: All three patients had a survival over six months after the management of the septic complication. Two of them received subsequent systemic anticancer treatment. Conclusions: Survival benefit offered by the management of cancer-related non-neutropenic sepsis may be comparable to the benefit obtained by systemic anticancer treatments. Cost-effectiveness of sepsis management may be better than that of anticancer treatments.